Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation

Microbiology and Immunology

Volumn 53, Issue 9, 2009, Pages 487-495

  Martinez, Rafael C R ^a   Seney, Shannon L ^b   Summers, Kelly L ^b,c   Nomizo, Auro ^a   De Martinis, Elaine C P ^a   Reid, Gregor ^b,c,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d ST JOSEPH S HEALTH CENTRE   (Canada)

Author keywords

Candida; Cytokine; Lactobacillus; Probiotic; Vulvovaginal candidiasis

Indexed keywords

CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; PROBIOTIC AGENT; RANTES; VASCULOTROPIN;

ARTICLE; CANDIDA ALBICANS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INCUBATION TIME; INFECTION; INFLAMMATION; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MICROORGANISM; NONHUMAN; SUPERNATANT; VAGINA CANDIDIASIS; YEAST;

CANDIDA ALBICANS; CANDIDIASIS, VULVOVAGINAL; CELL LINE; CYTOKINES; FEMALE; HUMANS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS; MODELS, BIOLOGICAL;

CANDIDA; CANDIDA ALBICANS; LACTOBACILLUS; LACTOBACILLUS REUTERI; LACTOBACILLUS RHAMNOSUS;

EID: 75749103762     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2009.00154.x     Document Type: Article

References (38)

1. Sobel J.D., Faro S., Force R.W., Foxman B., Ledger W.J., Nyirjesy P.R., Reed B.D., Summers P.R. (1998) Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 178: 203-11.
2. Steele C., Fidel P.L. Jr. (2002) Cytokine and chemokine production by human oral and vaginal epithelial cells in response to Candida albicans. Infect Immun 70: 577-83.
3. Ferrer J. (2000) Vaginal candidosis: epidemiological and etiological factors. Int J Gynecol Obstet 71: 21-7.
4. Sobel J.D. (1985) Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 152: 924-35.
5. Sobel J.D. (2007) Vulvovaginal candidosis. Lancet 369: 1961-71.
6. Schaller M., Mailhammer R., Korting H.C. (2002) Cytokine expression induced by Candida albicans in a model of cutaneous candidosis based on reconstituted human epidermis. J Med Microbiol 51: 672-6.
7. Trifonova R.T., Bajpai M., Pasicznyk J.M., Chandra N., Doncel G.F., Fichorova R.N. (2007) Biomarkers of leukocyte traffic and activation in the vaginal mucosa. Biomarkers 12: 608-22.
8. Fidel P.L. Jr., Lynch M.E., Redondo-Lopez V., Sobel J.D., Robinson R. (1993) Systemic cell-mediated immune reactivity in women with recurrent vulvovaginal candidiasis. J Infect Dis 168: 1458-65.
9. Fidel P.L. Jr., Barousse M., Espinosa T., Ficarra M., Sturtevant J., Martin D.H., Quayle A.J., Dunlap K. (2004) An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis. Infect Immun 72: 2939-46.
10. Owen M.K., Clenney T.L. (2004)Management of vaginitis. Am Fam Physician 70: 2125-32.
11. Lepargneur J.P., Rousseau V. (2002) Rôle protecteur de la flore de Doderleïn. J Gynecol Obstet Biol Reprod 31: 485-94.
12. Caruso L.J. (1964) Vaginal moniliasis after tetracycline therapy: the effects of amphotericin B. Am J Obstet Gynecol 90: 374-80.
13. Oriel J.D.,Waterworth P.M. (1975) Effect of mynocicline and tetracycline on the vaginal yeast flora. J Clin Pathol 28: 403-6.
14. FAO/WHO (2001) Evaluation of health and nutritional properties of powder milk and live lactic acid bacteria. Food and Agriculture Organization of the United Nations and World Health Organization Expert Consultation Report. http://www.fao.org.es/ESN/Probio/probio.htm.
15. Reid G., Sanders M.E., Gaskins H.R., Gibson G.R., Mercenier A., Rastall R., Roberfroid M., Rowland I., Cherbut C., Klaenhammer T.R. (2003) New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 37: 105-18.
16. Jeavons H.S. (2003) Prevention and treatment of vulvovaginal candidiasis using exogenous Lactobacillus. JOGNN 32: 287-96.
17. Martinez R.C.R., Franceschini S.A., Patta M.C., Quintana S.M., Candido R.C., Ferreira J.C., De Martinis E.C.P., Reid G. (2009) Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14. Lett Appl Microbiol 48: 269-274.
18. Kim S.O., Sheikh H.I., Ha S.D., Martins A., Reid G. (2006) G-CSF-mediated inhibition of JNK is a key mechanism for Lactobacillus rhamnosus-induced suppression of TNF production in macrophages. Cell Microbiol 8: 1958-71.
19. Lorea Baroja M., Kirjavainen P.V., Hekmat S., Reid G. (2007) Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 149: 470-9.
20. Barousse M.M., Espinosa T., Dunlap K., Fidel P.L. Jr. (2005) Vaginal epithelial cell anti-Candida albicans activity is associated with protection against symptomatic vaginal candidiasis. Infect Immun 73: 7765-7.
21. Hedges S.R., Agace W.W., Svanborg C. (1995) Epithelial cytokine responses and mucosal cytokine networks. Trends Microbiol 3: 266-70.
22. Hedges S., Agace W., Svensson M., Sjögren A.C., Ceska M., Svanborg C. (1994) Uroepithelial cells are part of a mucosal cytokine network. Infect Immunol 62: 2315-21.
23. Weinberg A., Krisanaprakornkit S., Dale B.A. (1998) Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 9: 399-414.
24. Wira C.R., Rossoll R.M. (1995) Antigen-presenting cells in the female reproductive tract: influence of the estrous cycle on antigen presentation by uterine epithelial and stromal cells. Endocrinology 136: 4526-34.
25. Fichorova R.N., Anderson D.J. (1999) Differential expression of immunobiological mediators by immortalized human cervical and vaginal epithelial cells. Biol Reprod 60: 508-14.
26. Breen E.C. (2007) VEGF in biological control. J Cell Biochem102: 1358-67.
27. Basu S., Quilici C., Zhang H.H., Grail D., Dunn A.R. (2008) Mice lacking both G-CSF and IL-6 are more susceptible to Candida albicans infection: critical role of neutrophils in defense against Candida albicans. Growth Factors 26: 23-34.
28. Appay V., Dunbar P.R., Cerundolo V., McMichael A., Czaplewski L., Rowland-Jones S. (2000) RANTES activates antigen-specific cytotoxic T lymphocytes in a mitogen-like manner through cell surface aggregation. Int Immunol 12: 1173-82.
29. Kullberg B.J., van't Wout J.W., van Furth R. (1990) Role of granulocytes in enhanced host resistance to Candida albicans induced by recombinant interleukin-1. Infect Immun 58: 3319-24.
30. Schmidt D.R., Kao W.J. (2007) The interrelated role of fibronectin and interleukin-1 in biomaterial-modulated macrophage function. Biomaterials 28: 371-82.
31. Fan S.R., Liao Q.P., Liu X.P., Liu Z.H., Zhang D. (2008) Vaginal allergic response in women with vulvovaginal candidiasis. Int J Gynecol Obstet 101: 27-30.
32. Baggiolini M., Clark-Lewis I. (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett 307: 97-101.
33. Djeu J.Y., Matsushima K., Oppenheim J.J., Shiotsuki K., Blanchard D.K. (1990) Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8. J Immunol 144: 2205-10.
34. Roebuck K.A. (1999) Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-KappaB (Review). Int J Mol Med 4: 223-30.
35. Spear G.T., Zariffard M.R., Cohen M.H., Sha B.E. (2008) Vaginal IL-8 levels are positively associated with Candida albicans and inversely with lactobacilli in HIV-infected women. J Reprod Immunol 78: 76-9.
36. Shiraki Y., Ishibashi Y., Hiruma M., Nishikawa A., Ikeda S. (2008) Candida albicans abrogates the expression of interferon-gamma-inducible protein-10 in human keratinocytes. FEMS Immunol Med Microbiol 54: 122-8.
37. Cadieux P., Burton J., Gardiner G., Braunstein I., Bruce A.W., Kang C.Y., Reid G. (2002) Lactobacillus strains and vaginal ecology. JAMA 287: 1940-1.
38. Kohler G., Reid G. (2005) Profiling the transcriptional response of Candida albicans to probiotic lactobacilli. ASM Conference on Beneficial Microbes, Lake Tahoe, Nevada, April 17-21. Published abstract.